 |
Director, Prevention and Early Intervention Program for Psychoses
ashok_dot_malla_At_douglas_dot_mcgill_dot_ca |
2004
Jensen J. E., Miller J., Williamson P. C., Neufeld R. W., Menon R. S., Malla A., Manchanda R., Schaefer B., Densmore M., Drost D. J. (2004). Focal changes in brain energy and phospholipid metabolism in first-episode schizophrenia: (31)P-MRS chemical shift imaging study at 4 Tesla, Br J Psychiatry, 184(5), 409-415.
Malla A., Norman R. M., McLean T. S., MacDonald C., McIntosh E., Dean-Lashley F., Lynch J., Scholten D., Ahmed R. (2004). Determinants of quality of life in first-episode psychosis, Acta Psychiatr Scand, 109(1), 46-54.
Malla A., Norman R. M., Takhar J., Manchanda R., Townsend L., Scholten D., Haricharan R. (2004). Can patients at risk for persistent negative symptoms be identified during their first episode of psychosis?, J Nerv Ment Dis, 192(7), 455-63.
Malla A., Norman R., Scholten D., Townsend L., Manchanda R., Takhar J., Haricharan R. (2004). A comparison of two novel antipsychotics in first episode non-affective psychosis: one-year outcome on symptoms, motor side effects and cognition, Psychiatry Res, 129(2), 159-69.
Manchanda R., Norman R. M., Malla A. (2004). Value of early intervention in psychosis, Br J Psychiatry, 185, 171; authors reply 171-2.
Norman R. M., Malla A., Verdi M. B., Hassall L. D., Fazekas C. (2004). Understanding delay in treatment for first-episode psychosis, Psychol Med, 34(2), 255-66.
Theberge J., Al-Semaan Y., Drost D. J., Malla A., Neufeld R. W., Bartha R., Manchanda R., Menon R., Densmore M., Schaefer B., Williamson P. C. (2004). Duration of untreated psychosis vs. N-acetylaspartate and choline in first episode schizophrenia: a 1H magnetic resonance spectroscopy study at 4.0 Tesla, Psychiatry Res, 131(2), 107-14.
